TRPC7 and neoplasm: Moreover, a dedicated cell-type specific analysis of TRPC3/TRPC7 mRNA abundancy in different tumor types that constitute PAAD parenchyma, such as peripheral nerve cells, immune cells, or vasculature compared to tumor cells, would be very helpful to narrow down the potential mechanism underlying the clinical prognostic value of our discovered biomarkers.